Repression of AXL expression by AP-1/JNK blockage overcomes resistance to PI3Ka therapy.

Added 1171 days ago (13.03.2019)
Authors: Badarni M, Prasad M, Balaban N, Zorea J, Yegodayev KM, Joshua BZ, Bahat Dinur A, Grénman R, Rotblat B, Cohen L, Elkabets M
PubMed id: 30860495
Read article